GlassScriptPhysician profile
Renee B Diamond
NPI 1295021392
$1,861.81
in general payments reported to CMS, 2019-2025
16 companies · $404 in 2025
The $404 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.58 · 2020: $55.46 · 2021: $262 · 2022: $422 · 2023: $391 · 2024: $312 · 2025: $404.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,093 · Education: $13.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,093.24 |
| Education | $13.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $815.01 | 2021-2025 | Ubrelvy, Linzess, Viberzi |
| Novo Nordisk INC | $376.45 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $151.26 | 2022-2025 | Mounjaro, Zepbound, Baqsimi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $123.55 | 2023-2025 | Jardiance |
| Vanda Pharmaceuticals INC. | $76.22 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $55.46 | 2020 | |
| Exact Sciences Corporation | $50.20 | 2023-2024 | Cologuard Collection Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $46.40 | 2025 | Entyvio |
| Kestra Medical Technology Services, INC. | $30.71 | 2023 | Assure Wcd |
| Amgen INC. | $29.28 | 2022-2023 | |
| Pfizer INC. | $22.71 | 2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $22.24 | 2022 | |
| Sanofi-Aventis U.S. LLC | $18.25 | 2025 | |
| Inspire Medical Systems, INC. | $15.26 | 2025 | Inspire |
| Shire North American Group INC | $14.58 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ardelyx, INC. | $14.23 | 2024 | Ibsrela |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Renee Diamond listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.